Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-04

Clinical Trial Update: Efficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax Malaria [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy of SJ733 in adults with uncomplicated Plasmodium falciparum or vivax malaria has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SJ733 (SJ733)

Snippet

Sponsor: R. Kiplin Guy | Conditions: Malaria, Falciparum, Malaria, Vivax | Phase 2 | Status: COMPLETED | Results posted: 2023-12-04